Cerebral Palsy
Conditions
Interventions
This study involves a randomized, controlled, single-blind clinical trial. The study will be carried out with children and adolescents with cerebral palsy, selected and divided through simple randomiz
E02.774
Sponsors
Centro de Estudos da Educação e Saúde - CER II - Universidade Estadual Paulista
Faculdade de Filosofia e Ciências da Universidade Estadual Paulista - Campus de Marília
Eligibility
Age
5 Years to 20 Years
Inclusion criteria
Inclusion criteria: Age between 5 and 20 years; both genders; cerebral palsy diagnosys; at levels I to V of the Gross Motor Function Classification System (GMFCS)
Exclusion criteria
Exclusion criteria: Individuals with neoplastic areas; bleeding episode; thermal sensitivity disorders; use of photosensitive drugs; have more than two consecutive faults
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect that photobiomodulation therapy may promote an autonomic balance, normalize levels of stress and inflammation-related biomarkers, act on melatonin, and improve sleep quality; assessed through the Children's Sleep Disturbance Scale, as well as by the Biologix device; reduce stool dryness and the interval of days between evacuations in individuals who present initial alterations, and increase the range of motion of passive knee extension | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactAna Stroppa Marques
CEES- CER II - Unesp - Faculdade de Filosofia e Ciências
Outcome results
None listed